Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 4
Open Label, Multi-center Roll-over Study to Assess Long Term Safety in Patients Who Have Completed a Global Novartis or GSK Sponsored Dabrafenib and/or Trametinib Study
This study is to provide access for patients who are receiving treatment with dabrafenib and/or trametinib in a Novartis-sponsored Oncology Global Development,…
MelanomaNon Small Cell Lung CancerSolid Tumor+2 more
Novartis PharmaceuticalsNCT03340506
NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors
Background: All childhood cancers are rare, but some are called very rare. Very rare cancers are diagnosed in 2 or fewer out of 1 million people each year. Re…
Very Rare TumorsVery Rare CancersOther Solid Tumors+2 more
National Cancer Institute (NCI)NCT07489378
Observational
TCF-001 TRACK (Target Rare Cancer Knowledge) Study
This open label, non-randomized, multi-center, pragmatic study aims to establish whether patients with rare tumors can benefit from matched molecular therapy a…
Rare CancersCholangiocarcinomaCancer of Unknown Primary Site
TargetCancer FoundationNCT04504604